Cargando…

Patient and provider experiences using a site-to-site telehealth model for medication abortion

BACKGROUND: In the site-to-site telehealth for medication abortion model, patients visit a health center to meet with a remote clinician using telehealth technology. This model is safe, effective, and acceptable to patients and providers. The objective of this study was to document the experiences o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggiero, Samantha P., Seymour, Jane W., Thompson, Terri-Ann, Kohn, Julia E., Snow, Jennifer L., Grossman, Daniel, Fix, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634192/
https://www.ncbi.nlm.nih.gov/pubmed/36338311
http://dx.doi.org/10.21037/mhealth-22-12
_version_ 1784824417004552192
author Ruggiero, Samantha P.
Seymour, Jane W.
Thompson, Terri-Ann
Kohn, Julia E.
Snow, Jennifer L.
Grossman, Daniel
Fix, Laura
author_facet Ruggiero, Samantha P.
Seymour, Jane W.
Thompson, Terri-Ann
Kohn, Julia E.
Snow, Jennifer L.
Grossman, Daniel
Fix, Laura
author_sort Ruggiero, Samantha P.
collection PubMed
description BACKGROUND: In the site-to-site telehealth for medication abortion model, patients visit a health center to meet with a remote clinician using telehealth technology. This model is safe, effective, and acceptable to patients and providers. The objective of this study was to document the experiences of patients and providers using telehealth for medication abortion in Planned Parenthood health centers across different geographical contexts in the United States. METHODS: We conducted in-depth interviews with Planned Parenthood medication abortion patients who either met with a clinician at the clinic via telehealth or in-person about their experiences receiving care. We also interviewed Planned Parenthood staff members about their experiences implementing telehealth for medication abortion at their health center. RESULTS: We interviewed 29 patients who received care at Planned Parenthood health centers in five states. Both telehealth and in-person patients described positive interactions with health center staff and clinicians. The vast majority of telehealth patients said that they felt comfortable speaking with the clinician over telehealth and had no trouble using the telehealth technology. We interviewed 12 providers, including clinicians and administrative staff, who worked in seven states. Providers largely thought that telehealth for medication abortion expanded access to medication abortion. CONCLUSIONS: Across different locations, our findings indicate that patients found telehealth for medication abortion services to be highly acceptable and providers found that telehealth services may help improve medication abortion access. As the use of telehealth for medication abortion expands, future research should include additional measures of quality to ensure that services are acceptable across different identities and experiences, including age, race, gender, and income level.
format Online
Article
Text
id pubmed-9634192
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-96341922022-11-05 Patient and provider experiences using a site-to-site telehealth model for medication abortion Ruggiero, Samantha P. Seymour, Jane W. Thompson, Terri-Ann Kohn, Julia E. Snow, Jennifer L. Grossman, Daniel Fix, Laura Mhealth Original Article BACKGROUND: In the site-to-site telehealth for medication abortion model, patients visit a health center to meet with a remote clinician using telehealth technology. This model is safe, effective, and acceptable to patients and providers. The objective of this study was to document the experiences of patients and providers using telehealth for medication abortion in Planned Parenthood health centers across different geographical contexts in the United States. METHODS: We conducted in-depth interviews with Planned Parenthood medication abortion patients who either met with a clinician at the clinic via telehealth or in-person about their experiences receiving care. We also interviewed Planned Parenthood staff members about their experiences implementing telehealth for medication abortion at their health center. RESULTS: We interviewed 29 patients who received care at Planned Parenthood health centers in five states. Both telehealth and in-person patients described positive interactions with health center staff and clinicians. The vast majority of telehealth patients said that they felt comfortable speaking with the clinician over telehealth and had no trouble using the telehealth technology. We interviewed 12 providers, including clinicians and administrative staff, who worked in seven states. Providers largely thought that telehealth for medication abortion expanded access to medication abortion. CONCLUSIONS: Across different locations, our findings indicate that patients found telehealth for medication abortion services to be highly acceptable and providers found that telehealth services may help improve medication abortion access. As the use of telehealth for medication abortion expands, future research should include additional measures of quality to ensure that services are acceptable across different identities and experiences, including age, race, gender, and income level. AME Publishing Company 2022-10-30 /pmc/articles/PMC9634192/ /pubmed/36338311 http://dx.doi.org/10.21037/mhealth-22-12 Text en 2022 mHealth. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Ruggiero, Samantha P.
Seymour, Jane W.
Thompson, Terri-Ann
Kohn, Julia E.
Snow, Jennifer L.
Grossman, Daniel
Fix, Laura
Patient and provider experiences using a site-to-site telehealth model for medication abortion
title Patient and provider experiences using a site-to-site telehealth model for medication abortion
title_full Patient and provider experiences using a site-to-site telehealth model for medication abortion
title_fullStr Patient and provider experiences using a site-to-site telehealth model for medication abortion
title_full_unstemmed Patient and provider experiences using a site-to-site telehealth model for medication abortion
title_short Patient and provider experiences using a site-to-site telehealth model for medication abortion
title_sort patient and provider experiences using a site-to-site telehealth model for medication abortion
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634192/
https://www.ncbi.nlm.nih.gov/pubmed/36338311
http://dx.doi.org/10.21037/mhealth-22-12
work_keys_str_mv AT ruggierosamanthap patientandproviderexperiencesusingasitetositetelehealthmodelformedicationabortion
AT seymourjanew patientandproviderexperiencesusingasitetositetelehealthmodelformedicationabortion
AT thompsonterriann patientandproviderexperiencesusingasitetositetelehealthmodelformedicationabortion
AT kohnjuliae patientandproviderexperiencesusingasitetositetelehealthmodelformedicationabortion
AT snowjenniferl patientandproviderexperiencesusingasitetositetelehealthmodelformedicationabortion
AT grossmandaniel patientandproviderexperiencesusingasitetositetelehealthmodelformedicationabortion
AT fixlaura patientandproviderexperiencesusingasitetositetelehealthmodelformedicationabortion